{"data":{"id":"us/21-cfr-330.2","jurisdiction":"us","citation":"21 CFR 330.2","heading":"Pregnancy-nursing warning.","body":"A pregnancy-nursing warning for OTC drugs is set forth under § 201.63 of this chapter.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 330—OVER-THE-COUNTER (OTC) HUMAN DRUGS WHICH ARE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED","Subpart A—General Provisions"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"d7f212d370131d1f2f695efc59622571fc0cc633fd184a769bdaab5610f6bcdb","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-330.1","next":"us/21-cfr-330.3"},"notice":"GroundRules: Original legal text. Not legal advice."}